Skin Specialist, PC dba Schlessinger MD

The trials here

What the 2 trials at this site are about, from their registry records.

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Verrica Pharmaceuticals Inc.2 trials

Running trials

• Recruiting

  Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

  NCT07457918· Phase 3· Verrica Pharmaceuticals Inc.· Source

  Contact: Project Manager

• Active, not recruiting

  Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

  NCT07246590· Phase 3· Verrica Pharmaceuticals Inc.· Source